http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 11 Sep 2026 03:14:49 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/New+Coverage/UBS+Starts+Korsana+Biosciences+%28KRSA%29+at+Buy/27050065.html <p>UBS analyst Michael Yee initiates coverage on Korsana Biosciences (NASDAQ: KRSA) with a Buy rating and a price target of $55.00.</p><p>The analyst comments: “We are initiating coverage of Korsana Biosciences KRSA at BUY with a $55 price target. We view lead asset KRSA-028 as a potential best-in-class treatment for early Alzheimer's disease leveraging brain shuttle tech to increase brain exposure and amyloid clearance while reducing ARIA risk and enabling more convenient dosing. Roche's trontinemab uses a similar TfR brain shuttle tech and had strong Phase I/II data with high efficacy and strong safety and pushed to Phase III which helps http://www.streetinsider.com/New+Coverage/UBS+Starts+Korsana+Biosciences+%28KRSA%29+at+Buy/27050065.html Fri, 11 Sep 2026 03:14:49 -0400 KRSA http://www.streetinsider.com/Analyst+Comments/UBS+Starts+Korsana+Biosciences+%28KRSA%29+at+Buy/27050065.html <p>UBS analyst Michael Yee initiates coverage on Korsana Biosciences (NASDAQ: KRSA) with a Buy rating and a price target of $55.00.</p><p>The analyst comments: “We are initiating coverage of Korsana Biosciences KRSA at BUY with a $55 price target. We view lead asset KRSA-028 as a potential best-in-class treatment for early Alzheimer's disease leveraging brain shuttle tech to increase brain exposure and amyloid clearance while reducing ARIA risk and enabling more convenient dosing. Roche's trontinemab uses a similar TfR brain shuttle tech and had strong Phase I/II data with high efficacy and strong safety and pushed to Phase III which helps http://www.streetinsider.com/Analyst+Comments/UBS+Starts+Korsana+Biosciences+%28KRSA%29+at+Buy/27050065.html Fri, 11 Sep 2026 03:14:49 -0400 KRSA